Germany Plans Beyond Corona With Investment In Health Care And Digital

 
• By Ashley Yeo
  
Generate a summary of this article
Listen to this article
Beta

Better health care infrastsructures, enhanced digital capabilities and temporary VAT cuts are part the German coalition government’s new investment plan to revive the economy in aftermath of COVID-19.

Covid19_Economic_Recovery

Temporary cuts in VAT rates for six months from 1 July and further investment in digital health care capabilities, artificial intelligence tools, hospital infrastructures, key pharmaceuticals and medical technologies and health care personal protective equipment (PPE): these are among the areas proposed to benefit from post-COVID-19 economic boost measures and a future-oriented strategic investment plan in Germany.

A document issued by the coalition committee on 3 June on “planning for the post-corona environment, securing the economy and...

Medtech Insight Podcast

Keep up with the top medtech business and regulatory news.

Medtech Insight brings you interviews and analysis, on the go.

SpotifyApple PodcastsWebsite

More from Germany

Dermanostic: A Legal Guinea Pig Impacted By MDR’s Regulatory Gaps?

 
• By Amanda Maxwell

With the latest ruling in Germany, there is speculation that the Medical Device Regulation’s confusing Article 11 on software or the device’s timing of gaining its class I category may be to blame for the invidious position Dermanostic has found itself in.

Why Notified Bodies Are Now The Focus Of Centralized Oversight Efforts

 
• By Amanda Maxwell

Proposals for substantial changes to oversight of medtech notified bodies are likely to be part of the European Commission’s targeted evaluation of the MDR and IVDR, EU medtech lawyer, Erik Vollebregt, tells Medtech Insight.

Amendment To MDR May Be First Legislative Proposal Of New European Commission

 
• By Amanda Maxwell

How Germany, which has the EU’s largest medtech manufacturing base, is pressing for the MDR to feature on the mission letter for the new European Commission and could influence the pace of change.

EU MDR Failings Aired At German Parliamentary Hearing

 
• By Ashley Yeo

MPs from across Germany’s political spectrum grilled a panel of national medtech stakeholders on the problems of the MDR and the EU regulatory system during an hour-long sitting of the Bundestag’s health committee on 5 June.

More from Europe

Biocomposites Fully Acquires SYNICEM And Subiton Lines, Launches NanoBone In UK

 
• By Natasha Barrow

UK-based Biocomposites will begin selling in the UK its next-generation osteoinductive bone graft substitute, NanoBone, which came with its acquisition of Artoss GmbH in June 2023. Meanwhile, the company has purchased remaining shares in the manufacturers of SYNICEM and Subiton antibiotic bone cements and preformed antibiotic-loaded spacers.

Abbott’s Share-Gobbling Aveir DR Leadless Pacing System Introduced To UK

 
• By Natasha Barrow

The firm’s dual-chamber leadless pacemaker system with is expected to be a growth driver for Abbott and already has acquired approximately 30%-40% of market share from Medtronic since its approval by the US FDA in July 2023, according to GlobalData.

Amferia Aims To Bring Peptide Hydrogel To Fight Against Antimicrobial Resistance

 
• By Natasha Barrow

Amferia is developing an antimicrobial peptide hydrogel dressing to combat infections in acute wounds in humans and veterinary contexts. Supported by €1.2m of new venture capital financing, the company is planning pivotal clinical studies to support an FDA application later this year and CE mark submission in 2026-2027.